BIOCHINA 2026 Surpasses 10,000 Registrations – Secure Your Spot Now

BIOCHINA 2026 has reached a major milestone, surpassing 10,000 registered attendees from around the world. This demonstrates the event’s growing influence as a premier platform for the global biopharmaceutical industry.

Participants at BIOCHINA 2026 can access a comprehensive range of opportunities across the full biopharma value chain. The Exhibition Pass provides entry to six halls featuring Laboratory Instruments, Pharma Equipment, Raw Materials & Reagents, Consumables, International Services, and General Services, enabling attendees to explore cutting-edge solutions and engage directly with suppliers.

The Forum Pass offers access to more than 250 specialized sessions, bringing together over 600 C-level executives from leading pharmaceutical companies. Attendees will gain insights into trends, innovations, and strategies spanning research and development, manufacturing, quality control, and clinical applications.

The BiOPartnering Pass opens the door to one-on-one meetings starting tomorrow. Over two-thirds of meeting rooms have already been reserved by top multinational corporations, leading pharma companies, and innovative biotech firms. Nearly 1,000 investors, executives, founders, and business development leaders are ready to connect on the platform, offering unparalleled networking and collaboration opportunities.

BIOCHINA 2026 is the essential destination for professionals seeking to expand global partnerships, explore licensing opportunities, and engage with the latest industry innovations. Don’t miss your chance to join this vibrant biopharma community.

Register now to secure your participation: https://u.morebio.cn/MnEjmeQF

Learn more about the event: https://www.biocn.cn/en/en.html